Lovastatin
Temporal Lobe Epilepsy
University of CoimbraSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Temporal Lobe Epilepsy cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Cipralex Conrad, Erich J., M.D. | Phase 4 | BB |
Same molecule, other indications
Lovastatin is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →